Re: [新聞] Novavax候選疫苗效力89.3% 可望加入抗疫

Suggestion: SOLD

My average cost per share: $5.8

All of my shares were sold at $170 today.

As the market is experiencing high volatility, I’d suggest one be more conservative. That the 89.3% sounds an impressive number does not mean the NVAX canactually make profit. NVAX stock price may rise in a few week, but will return to the price that it used to be in the long run. If you bought NVAX at the price lower than $110 you should close parts of your position to hedge.

--